John S. Yu
CEO and Chairman at Kairos Pharma Ltd.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: Kairos Pharma Ltd., 2 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Kairos Pharma Ltd. June 10, 202599.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 8, 2025 | Kairos Pharma Ltd. | Grant or award | +190,840 | — | — |
| Jan 1, 2025 | Kairos Pharma Ltd. | Grant or award | +14,000 | — | — |
| Nov 20, 2024 | Kairos Pharma Ltd. | Open-market purchase | +4,000 | $1.44 | $5,760 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.